anagrelide

Known as: Anagrelida, Anagrelidum, anagrelide [Chemical/Ingredient] 
A synthetic quinazoline derivative, Anagrelide reduces platelet production through a decrease in megakaryocyte maturation. Anagrelide inhibits cyclic… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
High platelet counts in essential thrombocythemia (ET) can be effectively lowered by treatment with either anagrelide or… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND We conducted a randomized comparison of hydroxyurea with anagrelide in the treatment of essential thrombocythemia… (More)
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND An acquired V617F mutation in JAK2 occurs in most patients with polycythaemia vera, but is seen in only half those… (More)
Is this relevant?
2004
2004
BACKGROUND AND OBJECTIVES Although anagrelide is widely used in the treatment of thrombocythemia in myeloproliferative diseases… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2004
2004
In this retrospective multi-centre study, we report our experience with anagrelide in the treatment of thrombocytosis in patients… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Anagrelide is a novel platelet-lowering agent that has recently been approved for use in essential thrombocythemia (ET) and… (More)
Is this relevant?
Review
1997
Review
1997
This report suggests modest changes in the criteria used for the diagnosis of ET and allows tentative recommendations concerning… (More)
Is this relevant?
1997
1997
Anagrelide, an inhibitor of platelet aggregation, decreases the number of platelets in normal subjects and in patients with… (More)
Is this relevant?
1992
1992
PURPOSE To evaluate the safety and efficacy of anagrelide when used to reduce platelet counts in patients with thrombocytosis… (More)
Is this relevant?
1988
1988
Anagrelide is a member of the imidazo (2,1-b) quinazolin-2-one series of compounds, with a powerful antiaggregating effect on… (More)
Is this relevant?